ก ก ก FCYP2A6 F F Inhibitory Studies of the Human Cytochrome P450

Total Page:16

File Type:pdf, Size:1020Kb

ก ก ก FCYP2A6 F F Inhibitory Studies of the Human Cytochrome P450 – – . กกก CYP2A6 Inhibitory studies of the human cytochrome P450, CYP2A6, the nicotine metabolizing enzyme by Thai herbal and fruit juices ก กกก (.) กกก กกก CYP2A6 กก กกกก (.) ก กก Prof. dr. Jung-Ja P.Kim ก Medical College of Wisconsin Assoc. Prof. dr. Emily E. Scott ก University of Kansus ก ก rat CPR CYP2A6 ก Prof. dr. Joyce A. Goldstein ก National Institute of Health (NIH) ก กกกก P450 CYP3A4 CYP2C9 .. ก กกกกก กก-กกกก กก ก กกก CYP2A6 ก Cytochrome P450 2A6 (CYP2A6) ก cytochrome P450 (CYP P450) ก heme กกก กก ก CYP2A6 กกกก Km Vmax กกกก CYP2A6 กกกกกก กก ก CYP2A6 กกก กก CYP2A6 ก กก ก CYP2A6 กกก CYP2A6 กกก coumarin Km 1 uM ก 25 3% v/v ก CYP2A6 50% 95% 40% v/v กกกก CYP2A6 mechanism-based กก CYP3A4 CYP2C9 กก ก CYP2A6 ก กกก Abstract Project Title Inhibitory studies of the human cytochrome P450, CYP2A6, the nicotine metabolizing enzyme by Thai herbal and fruit juices Investigators Songklod Sarapusit, Ph.d, department of Biochemistry, Faculty of Science, Burapha University Pornpimol Rongnoparut, Ph.d, department of Biochemistry, Faculty of Science, Mahidol University Cytochrome P450 2A6 (CYP2A6) is the heme-containing protein that belongs to the cytochrome P450 (CYP or P450) super-family. In human, P450 enzymes play an essential role in metabolism of various endogenous and exogenous compounds such as hormones drugs and many environmental toxicants. The human CYP2A6 enzyme could specifically metabolize nicotine, an additive compound in cigarette, with high efficiency (low Km and high Vmax value). Therefore, nicotine metabolism by the liver-specific human CYP2A6 enzymes has been report as an important route in nicotine detoxification. In addition, some of deficient CYP2A6 allele smokers that drastically decrease in nicotine metabolizing activity of CYP2A6 enzyme tend to smoke few cigarettes per day and are low-risk of nicotine dependence compared to the normal allele smokers. This study aims to screen for Thai herbal juices or fruit juices that could specifically inhibit CYP2A6 enzymatic activity in vitro . As the results, the bacterially expressed and purified human CYP2A6 enzyme is functionally active and is specifically metabolized the coumarin substrate with the K m value approximately 1 uM. Out of 25 herbal and fruit juices tested, an in vitro experiment indicated that only 3% v/v of the Star fruit juice could inhibit CYP2A6-mediated coumarin hydroxylation by 50%. Interestingly, almost 95% of CYP2A6-mediated coumarin hydroxylation was inhibited in the presense of 40% v/v of the Star fruit juice in vitro. Further study indicated Star fruit juice could inhibit CYP2A6 activity by mechanism-based inactivaition process. However, Star fruit juice could also inhibit human CYP3A4 and CYP2C9 activity in vitro . Therefore, care must be taken in cessation smokers who orally take drugs that metabolized by CYP3A4 and CYP2C9 enzyme, a highly distribute human-drug metabolizing enzymes. 1 1.1 กกกก กกก ก กกก 1,100 3,000,000 6 (WHO,2008) กก .. 2550 10.86 ก 20% ก ( 2551) ก กก กก 2 6 10 ก 5-8 กกกก กกก Cytochrome P450 2A6 (CYP2A6) ก Cytochrome P450 (CYP P450) กกกก ก CYP2A6 Km Vmax (Patten et al., 1996) ก CYP2A6 กกกกกก (Hukkanen et al., 2002; Miksys et al., 2002; Su et al., 2000) กกกก CYP2A6 ก CYP2A6 กกกก กกก CYP2A6 ก กก CYP2A6 กกก 8-methoxypsoralrn (8-MOP) ก CYP2A6 ก (Hukkanen et al., 2005) กก 8-MOP กก ก ก CYP2A6 ก กกกก กกก ก กก CYP2A6 กกก กกก CYP2A6 กกก XL-1 blue กก กก ก CYP2A6 ก 50% (IC 50 ) 3% v/v กกกก CYP2A6 ก mechanism based ก ก CYP3A4 CYP2C9 กก ก CYP2A6 ก กกก 1.2ก 1. กกก CYP2A6 2. กกก CYP2A6 1.3กก กก CYP2A6 1.4กก CYP2A6 กก P450 1.5 ก ก (Tranformation) (Competent cell) กก กก CYP2A6 XL-1 blue rat CPR C41 (dE3) SdS-PAGE กกก coumarin กกก CYP2A6 กก กก ( 1-1) กกกกก กกกก dNA CYP2A6 dNA CYPOR กก CYP2A6 CYPOR ก CYP2A6 CYPOR 1-1 กก 2 ก 2.1 ก Cytochrome P450 (CYPs P450s) กกก ก ก ก ก กก P450 ก ก P450s กกก P450 กกกกก ก (Family) กกกก 40 ก (Subfamily) กกกกก 55 ก P450s ก กกกกก P450s กกกกกกก P450s กกกก 1 ก (Bernhardt R, 2006; Mansuy d, 1998; Nelson et al, 1996; Ortiz, 2005) 2-1 ก P450s กกกกก ( 1- 6) กกกก ( 7 8) ก ( 9) Guengerich FG, 2001 กกก P450s ( 2-1) P450s ก ก NAdPH-cytochrome P450 reductase (CPR) กกก (Fe 3+ Fe 2+) ก P450s P450s กก ก กกกกกก กก (iron-hydroxy complex) กกก ก Endoplasmic reticulum กก Squalene monooxygenase, Heme oxygenase ก Cytochrome P450 กกกก (Bernhardt R, 2006; Emre M et al, 2007; Guengerich FG, 2001; Ortiz, 2005) ก cytochrome c ferricyanideก ( 2-2) 2-2 ก NAdPH-cytochrome P450 reducatse ก www.uky.edu/Pharmacy/ps/porter/CPR.htm PLEASE specify reference CPR กกก FAd FMN กก กกก NAdPH ก FAd FMN กก ก CPR ก P450s กก กก CPR CPR , ก (Shen et al., 1989; dohr et al., 2001; Murataliev et al, 1999) กกก CPR CPR ก 4 NH 2-terminal, FMN-binding domain, FAd-binding domain, NAdPH-binding domain (Wang et al., 1997) FMN domain ก ก FAd-binding domain NAdPH-binding domain ก ( 2-3) NAdPH-binding domain FAd -binding domain FMN -binding domain 2-3 Cytochrome P450s () P450s Oxoidoreductase () ก Endoplasmic reticulum 2.2 ก กก ก 2549 กกกก ก 9.86 (Leartsakulpanitch et al , 2007) ก .. 2552 10.90 20.70 กกก 15 52.7 23.04 ( 25-59 ) ก 10.40 0.54 กกกก กก กก กก กก 58.95 6.39 17,059 84.78 ก กกกกกก ก กกก 30.4 4.7 กก 15.6 ( 10.9 ) 1.77 ก กก//ก 38.61 27.42 ก 11.44 กกก ก 20 กกก กกก ( 2551, 2552) กกก กกกก 4,000 กก 40 กก กกก กกกก (WHO, 2008) กกกก ก กก (WHO, 2008) กกก กกกก ก กก กกก ก ก กกกก ก (Hukkanen et al, 2005) กก ก (Benowitz, 2008) กกก (Oral mucosa) 80-90% กก กกกกกก (Beno- witz, 2008; Flammang et al, 1992) ก CYP2A6 ก ก nicotine ∆1(5) - iminium (Hukkanen et al, 2005) กกกก hydroxylation ก trans -3-hydroxycotinine, 5-hydroxycotinine nornicotine ( 2-4) กก ก (glucoronation) ก ก cytochrome P450 (CYP P450) ก heme ก กกกกก ก P450 18 ก (Family) 43 ก (Sub-family) (http://drnelson.utmen.edu/CytochromeP450.html ) CYP2A6 , CYP2A13 , CYP2B6 ก , CYP2d6 CYP2E1 กกก (Hukkanen et al, 2002; Miksys et al, 2002; Su et al, 2000) CYP2A6 Km Vmax (Patten et al, 1996) CYP2A13 กก CYP2B6 CYP2d6 กก (Benowitz et al, 1996) CYP2E1 กกก alcohol กก (McCarver et al, 1998) กก กก ก CYP2A6 กกกกกก 2-4 กกกก (Hukkanen et al, 2005) กกกก CYP2A6 ก coumarin 7-hydroxycoumarin (ก coumarin-7-hydroxylase) coumarin ก CYP2A6 (Miles et al, 1990; Yamano et al, 1990) กก CYP2A6 chlormethiazole กก nitrosamine NNK [4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone] NNAL [4- methylnitrosamino)-1-(3-pyridyl)-1-butanol] NNN [ N9-nitrosonornicotine] (Patten et al, 1996; Pelkonen et al, 2000;Peterson et al, 1990) ก (Hecht, 1998; Hecht, 1999a, 1999b) กกกกก (Polymorphism) CYP2A6 ก กก 37 กก (http://www.imm.ki.
Recommended publications
  • Anti-Inflammatory Activity of Compounds from Kaempferia Marginata Rhizomes
    Songklanakarin J. Sci. Technol. 39 (1), 91-99, Jan. - Feb. 2017 http://www.sjst.psu.ac.th Original Article Anti-inflammatory activity of compounds from Kaempferia marginata rhizomes Kanidta Kaewkroek1, Chatchai Wattanapiromsakul1, 2, Hisashi Matsuda3, Seikou Nakamura3, and Supinya Tewtrakul1, 2* 1 Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, 90112 Thailand 2 Excellent Research Laboratory, Phytomedicine and Phamaceutical Biotechnology Excellence Center, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Songkhla, 90112 Thailand 3 Kyoto Pharmaceutical University, Misasagi, Yamashina-ku, Kyoto, 607-8412 Japan Received: 12 January 2016; Revised: 12 April 2016; Accepted: 19 April 2016 Abstract Two new pimarane diterpenes were obtained from Kaempferia marginata rhizomes, which are 1-acetoxysandara- copimaradien-2-one (1) and 1-acetoxysandaracopimaradiene (4), along with seven known compounds from the hexane and chloroform fractions including two pimarane-type diterpenes [marginatol (5), sandaracopimaradiene (8)], one kavalactone [desmethoxyyangonin (3)], three steroids [sitosterol--D-glucoside (2), the mixture of stigmasterol and -sitosterol (6 + 7)] and one diarylheptanoid [bisdemethoxycurcumin (9)]. Compounds 3 and 9 exhibited potent effect against NO production with IC50 of 10.1 and 6.8 µM, respectively. Compound 3 inhibited iNOS mRNA expression in a dose-dependent manner, while 9 suppressed both of iNOS and COX-2 genes. Moreover, compounds 2, 3, 6 + 7 and 9 were isolated for the first time from K. marginata. These results revealed that diterpenes, diarylheptanoid and kavalactone are components of K. marginata that afford anti-inflammatory effect through a mechanism involving a decrease in inflammatory mediators. Keywords: Kaempferia marginata, diterpenes, diarylheptanoid, kavalactone, anti-inflammatory activity 1.
    [Show full text]
  • Herbal Insomnia Medications That Target Gabaergic Systems: a Review of the Psychopharmacological Evidence
    Send Orders for Reprints to [email protected] Current Neuropharmacology, 2014, 12, 000-000 1 Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence Yuan Shia, Jing-Wen Donga, Jiang-He Zhaob, Li-Na Tanga and Jian-Jun Zhanga,* aState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China; bDepartment of Pharmacology, School of Marine, Shandong University, Weihai, P.R. China Abstract: Insomnia is a common sleep disorder which is prevalent in women and the elderly. Current insomnia drugs mainly target the -aminobutyric acid (GABA) receptor, melatonin receptor, histamine receptor, orexin, and serotonin receptor. GABAA receptor modulators are ordinarily used to manage insomnia, but they are known to affect sleep maintenance, including residual effects, tolerance, and dependence. In an effort to discover new drugs that relieve insomnia symptoms while avoiding side effects, numerous studies focusing on the neurotransmitter GABA and herbal medicines have been conducted. Traditional herbal medicines, such as Piper methysticum and the seed of Zizyphus jujuba Mill var. spinosa, have been widely reported to improve sleep and other mental disorders. These herbal medicines have been applied for many years in folk medicine, and extracts of these medicines have been used to study their pharmacological actions and mechanisms. Although effective and relatively safe, natural plant products have some side effects, such as hepatotoxicity and skin reactions effects of Piper methysticum. In addition, there are insufficient evidences to certify the safety of most traditional herbal medicine. In this review, we provide an overview of the current state of knowledge regarding a variety of natural plant products that are commonly used to treat insomnia to facilitate future studies.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0311593 A1 Fischer Et Al
    US 20100311593A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0311593 A1 Fischer et al. (43) Pub. Date: Dec. 9, 2010 (54) HALOALKYLMETHYLENEOXYPHENYL- AOIPI3/00 (2006.01) SUBSTITUTED KETOENOLS C07D 207/00 (2006.01) C07D 305/12 (2006.01) (75) Inventors: Reiner Fischer, Monheim (DE): CD7C 49/00 (2006.01) Thomas Bretschneider, Lohmar C07D 23/00 (2006.01) (DE); Stefan Lehr, Liederbach C07C 229/00 (2006.01) (DE); Eva-Maria Franken, Lyon C07C 69/76 (2006.01) (FR): Olga Malsam, Rosrath (DE); CD7C 24I/00 (2006.01) Arnd Voerste, Koln (DE); Ulrich CD7C 63/04 (2006.01) Görgens, Ratingen (DE); Jan (52) U.S. Cl. ......... 504/219;564/170; 514/622:504/336; Dittgen, Frankfurt (DE); Dieter Feucht, Eschborn (DE); Isolde 504/236; 514/248; 544/235; 540/545; 514/211.08; Hauser-Hahn, Leverkusen (DE); 548/544; 549/319; 568/379: 548/366.4; 560/37; Christopher Hugh Rosinger, 560/76; 560/105:564/149; 562/493 Hofheim (DE); Alfred Angermann, Kriftel (DE) (57) ABSTRACT The invention relates to novel compounds of the formula (I), Correspondence Address: STERNE, KESSLER, GOLDSTEIN & FOX P.L. L.C. (I) 1100 NEW YORKAVENUE, N.W. WASHINGTON, DC 20005 (US) (73) Assignee: Bayer Cropscience AG, Monheim (DE) (21) Appl. No.: 12/639,536 (22) Filed: Mar. 11, 2010 in which W, X, Y, Z and CKE are each as defined above, to several methods and intermediates for preparation thereof (30) Foreign Application Priority Data and to the use thereofas pesticides and/or herbicides. The invention also relates to selective herbicidal composi Mar.
    [Show full text]
  • Kava - the Unfolding Story: Report on a Work-In-Progress
    Article Kava - the unfolding story: Report on a work-in-progress. Denham, Alison, McIntyre, Michael and Whitehouse, Jule Available at http://clok.uclan.ac.uk/9455/ Denham, Alison, McIntyre, Michael and Whitehouse, Jule Kava - the unfolding story: Report on a work-in-progress. Journal of Alternative and Complementary Medicine, 8 (3). pp. 237-263. It is advisable to refer to the publisher’s version if you intend to cite from the work. For more information about UCLan’s research in this area go to http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>. For information about Research generally at UCLan please go to http://www.uclan.ac.uk/research/ All outputs in CLoK are protected by Intellectual Property Rights law, including Copyright law. Copyright, IPR and Moral Rights for the works on this site are retained by the individual authors and/or other copyright owners. Terms and conditions for use of this material are defined in the policies page. CLoK Central Lancashire online Knowledge www.clok.uclan.ac.uk THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 8, Number 3, 2002, pp. 237–263 © Mary Ann Liebert, Inc. SPECIAL REPORT Kava—the Unfolding Story: Report on a Work-in-Progress ALISON DENHAM, B.A. (Soc.), M.N.I.M.H., 1 MICHAEL McINTYRE, M.A., F.N.I.M.H., F.R.C.H.M., M.B.Ac.C., 2 and JULIE WHITEHOUSE, Ph.D., M.N.I.M.H. 3 ABSTRACT This paper, originated as a submission (now updated) to the U.K. Medicines Control Agency and Committee of Safety of Medicines (CSM) on January 11, 2002, in response to a report circu- lated by the German Federal Institute for Drugs and Medical Products (German initials are BfArM), a compilation of which is summarized in Appendix 2.
    [Show full text]
  • Kava Kava Extract Is Available from Ashland Chemical Co., Mini Star International, Inc., and QBI (Quality Botanical Ingredients, Inc.)
    SUMMARY OF DATA FOR CHEMICAL SELECTION Kava Kava 9000-38-8; 84696-40-2 November 1998 TABLE OF CONTENTS Basis for Nomination Chemical Identification Production Information Use Pattern Human Exposure Regulatory Status Evidence for Possible Carcinogenic Activity Human Data Animal Data Metabolism Other Biological Effects Structure-Activity Relationships References BASIS OF NOMINATION TO THE CSWG Kava kava is brought to the attention of the CSWG because it is a rapidly growing, highly used dietary supplement introduced into the mainstream U.S. market relatively recently. Through this use, millions of consumers using antianxiety preparations are potentially exposed to kava kava. A traditional beverage of various Pacific Basin countries, kava clearly has psychoactive properties. The effects of its long-term consumption have not been documented adequately; preliminary studies suggest possibly serious organ system effects. The potential carcinogenicity of kava and its principal constituents are unknown. INPUT FROM GOVERNMENT AGENCIES/INDUSTRY The U.S. Pharmacopeia is in the process of reviewing kava kava. No decision on preparation of a monograph has been made. SELECTION STATUS ACTION BY CSWG: 12/14/98 Studies requested: - Toxicological evaluation, to include studies of reproductive toxicity and neurotoxicity - Genotoxicity Priority: High Rationale/Remarks: - Significant human exposure - Leading dietary supplement with rapidly growing use - Concern that kava has been promoted as a substitute for ritilin in children - Test extract standardized to 30 percent kavalactones - NCI is conducting studies in Salmonella typhimurium CHEMICAL IDENTIFICATION CAS Registry Number: 9000-38-8 Kava-kava resin (8CI) Chemical Abstract Service Name: 84696-40-2 CAS Registry Number: Pepper (Piper), P. methysticum, ext. Chemical Abstract Service Name: Extract of kava; kava extract; Piper Synonyms and Trade Names: methisticum extract Description: The tropical shrub Piper methysticum is widely cultivated in the South Pacific.
    [Show full text]
  • A Review of the Literature
    Pharmacogn J. 2019; 11(6)Suppl:1511-1525 A Multifaceted Journal in the field of Natural Products and Pharmacognosy Original Article www.phcogj.com Phytochemical and Pharmacological Support for the Traditional Uses of Zingiberacea Species in Suriname - A Review of the Literature Dennis RA Mans*, Meryll Djotaroeno, Priscilla Friperson, Jennifer Pawirodihardjo ABSTRACT The Zingiberacea or ginger family is a family of flowering plants comprising roughly 1,600 species of aromatic perennial herbs with creeping horizontal or tuberous rhizomes divided into about 50 genera. The Zingiberaceae are distributed throughout tropical Africa, Asia, and the Americas. Many members are economically important as spices, ornamentals, cosmetics, Dennis RA Mans*, Meryll traditional medicines, and/or ingredients of religious rituals. One of the most prominent Djotaroeno, Priscilla Friperson, characteristics of this plant family is the presence of essential oils in particularly the rhizomes Jennifer Pawirodihardjo but in some cases also the leaves and other parts of the plant. The essential oils are in general Department of Pharmacology, Faculty of made up of a variety of, among others, terpenoid and phenolic compounds with important Medical Sciences, Anton de Kom University of biological activities. The Republic of Suriname (South America) is well-known for its ethnic and Suriname, Paramaribo, SURINAME. cultural diversity as well as its extensive ethnopharmacological knowledge and unique plant Correspondence biodiversity. This paper first presents some general information on the Zingiberacea family, subsequently provides some background about Suriname and the Zingiberacea species in the Dennis RA Mans country, then extensively addresses the traditional uses of one representative of the seven Department of Pharmacology, Faculty of Medical Sciences, Anton de Kom genera in the country and provides the phytochemical and pharmacological support for these University of Suriname, Kernkampweg 6, uses, and concludes with a critical appraisal of the medicinal values of these plants.
    [Show full text]
  • Piper Methysticum)
    Journal of Student Research (2015) Volume 4, Issue 2: pp. 69-72 Research Article A Closer Look at the Risks vs. Benefits of Kava (Piper methysticum) Anan A. Husseina If you took a trip to Fiji, the locals would probably welcome you with a drink of Kava. For centuries, the indigenous people of the South Pacific Islands have used the roots of a plant known as Kava. Beyond the use of Kava as a psychoactive substance, it has been incorporated as a cultural drink that is used in many ceremonies. In the late 1990’s Kava use spread quickly in Western countries including Europe, North America, and Australia. It was used as a treatment for anxiety. But just as quickly as it spread, the enthusiasm for it faded, because it was banned or restricted in many Western countries following reports of liver toxicity. In the United States, the Food and Drug Administration’s (FDA) concern for safety prompted a request for more research on the substance. The issues of safety and efficacy remain more specifically whether the benefits of using Kava outweigh the risks. History Kava is a beverage made from the roots of the plant included alcohol, cocaine, tobacco, and heroin. The findings Piper methysticum, and has been used historically in the suggest that kava may reduce the craving associated with the South Pacific Islands as a ceremonial drink. Kava was aforementioned substances, which may make kava a great introduced in Europe around the 1700s by Captain James future candidate to help with addiction. 13 Cook and has since spread widely to Australia, Europe, and Although the mechanism of action is not clear, it is the United States.
    [Show full text]
  • Cover Next Page > Cover Next Page >
    cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_i next page > Page i The Psychopharmacology of Herbal Medicine < previous page page_i next page > cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_ii next page > Page ii This page intentionally left blank. < previous page page_ii next page > < previous page page_iii next page > Page iii The Psychopharmacology of Herbal Medicine Plant Drugs That Alter Mind, Brain, and Behavior Marcello Spinella < previous page page_iii next page > < previous page page_iv next page > Page iv © 2001 Massachusetts Institute of Technology All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher. This book was set in Adobe Sabon in QuarkXPress by Asco Typesetters, Hong Kong and was printed and bound in the United States of America.
    [Show full text]
  • Kavain Analogues As Potential Analgesic Agents
    Pharmacological Reports Copyright © 2012 2012, 64, 14191426 by Institute of Pharmacology ISSN 1734-1140 Polish Academy of Sciences Kavainanaloguesaspotentialanalgesicagents ElaineC.Kormann1,PatriciadeAguiarAmaral2,MicheleDavid3, VeraL.Eifler-Lima4,ValdirCechinelFilho1,FátimadeCamposBuzzi1 1 Chemical-PharmaceuticalInvestigationsCenter(NIQFAR)/CCS,UniversityofItajaíValey(UNIVALI),Itajaí/SC, Brazil 2 LaboratoryofMedicinalPlants(LaPlaM),UniversityoftheExtremeSouthofSantaCatarina(UNESC), Criciúma/SC,Brazil 3 LaboratoryofChemistryTherapeutic(UPRES4090),UniversityofRennes1,Rennes,France 4 LaboratoryofMedicinalOrganicSynthesis(LaSOM),FacultyofPharmacy,FederalUniversityofRioGrande doSul(UFRGS),PortoAlegre/RS,Brazil Correspondence: FátimadeCamposBuzzi,e-mail: [email protected]; VeraL.Eifler-Lima, e-mail: [email protected] Abstract: Background: Kavalactones are pharmacologically active compounds present in preparations of the root trunk of Piper methysticum Forst, known as kava. This work describes the analgesic activity of some synthesized analogues of synthetic kavain, which is the maincomponentofkava. Methods: The essays were initially performed against the writhing test in mice, and the most promising compound was analyzed us- ing other classical models of nociception, including formalin-, capsaicin-, glutamate-induced nociception, the hot plate test, and measurementofmotorperformance. Results: The results indicated that compound 6-(4-fluorophenyl)-4-methoxy-5,6-dihydropyran-2-one (2d) exerts potent and dose- dependent analgesic activity, inhibiting abdominal constrictions caused by acetic acid in mice, and being more active than some ref- erence drugs. It also presented activity in the other models of pain, with the exception of the hot plate test and the measurement of motorperformance. Conclusions: Although compound 2d exerts antinociceptive activity, the mechanism of action remains uncertain, but it does not in- volve the opioid system and does not appear to be associated with non-specific effects such as changes in locomotor activity or motor coordination.
    [Show full text]
  • The Dietary Supplement Health and Education Act of Consulting Services, White Rock, B.C., Wade Davis, Ph.D
    New Products from ABC's Herbal Education Catalog The ABC Clinical Guide to Herbs Ed. by Mark Blumenthal et al. , Ameri can Botanical Council , 2003. How does the healthcare professional effectively respond to pati ent inquiries on the use of herbal supplements? What clinical research has been conducted? How is safety evaluated? T his science-based educati onal course answers these and other ques­ tions for healthcare professionals, pharmaceutical companies, health management compani es, policy makers, the dietary supplement industry and consumers. Hardcover, 512 pp. $49.95. #905 Quick Access Guide to Conditions, Herbs & Supplements by Integrative Medicine Communica ti ons, 2000. T his book has three broad categories for quick answers to consumer questio ns. T he largest section deals with co nditions and covers various treatment options incl uding herbs, supplements, drugs, and other complementary and alternative therapies. O nly alternative treatments that are considered safe and effective when used with conventional medicine are included. Additional sections on herbs and supplements cover bas ic informati on, precautions, and dosage informati on. T he Q uick Reference Guide fou nd at the end of the book shows at a glance all the herbs and supplements that are useful in treating that co ndition. Softcove r. 430 pp. $29.95. #B52 1. Special offe r $24.00! ~ Quick Access Patient Information on Conditions, Herbs I ..!~ I & Supplements ~. I by Integrative Medicine Communications. Consists of three types of monographs. Condition monographs ~ provide patients with information on standard medical care wi th additional information on nutritional ._. support and the use of alternative and complementary therapies.
    [Show full text]
  • Assessment Report on Piper Methysticum G. Forst., Rhizoma Based on Article 10A of Directive 2001/83/EC (Well-Established Use)
    22 November 2016 EMA/HMPC/450589/2016 Committee on Herbal Medicinal Products (HMPC) Assessment report on Piper methysticum G. Forst., rhizoma Based on Article 10a of Directive 2001/83/EC (well-established use) Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC (traditional use) Draft Herbal substance(s) (binomial scientific name of the plant, including plant part) Piper methysticum G. Forst., rhizoma Herbal preparation(s) Not applicable Pharmaceutical form(s) Not applicable Rapporteur C. Purdel Peer-reviewer O. Palomino Note: This draft assessment report is published to support the public consultation of the draft public statement on Piper methysticum, rhizoma. It is a working document, not yet edited, and shall be further developed after the release for consultation of the public statement. Interested parties are welcome to submit comments to the HMPC secretariat, which will be taken into consideration but no ‘overview of comments received during the public consultation’ will be prepared on comments that will be received on this assessment report. The publication of this draft assessment report has been agreed to facilitate the understanding by Interested Parties of the assessment that has been carried out so far and led to the preparation of the draft public statement. 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union © European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ..................................................................................................................
    [Show full text]
  • Lavender Display Until May 1, 2007
    Japanese Herbs for Liver Health • Green Tea Health Benefits • Kudzu Reduces Alcohol Consumption The Journal of the American Botanical Council Number 73 | USA $6.95 | CAN $7.95 Medicinal Herb Conservation Herbs for Liver Disease Versatile Lavender Display until May 1, 2007 www.herbalgram.org www.herbalgram.org 2007 HerbalGram 73 | 1 2 | HerbalGram 73 2007 www.herbalgram.org Herb Profile Lavender Lavandula angustifolia Mill. (Syn: L. officinalis Chaix., L. spica L., L. vera DC.) INTRODUCTION Family: Lamiaceae (Labiatae) avender is an aromatic subshrub native to lavender oil is massaged into the temples, it can help relieve many forms of headache. It can also relieve the low mountains (1,970-3,940 feet) of many causes of muscular pain. In aromatherapy, Lthe Mediterranean basin. It is cultivated in lavender is used for many varied skin conditions, France, Albania, Bulgaria, Hungary, Italy, Spain, including insect bites, burns, inflammation, and for the nations of the former Yugoslavia (Montene- healing small cuts.9,10 gro, Serbia, etc.), China, Russia, Moldova, Argen- Fresh lavender flowers are added to jams, ice cream, tina, the Netherlands, the United Kingdom, the vinegar, and herbal teas.11 The aromatic oil possesses United States, and Australia.1,2,3,4 It should not a soothing fragrance used to scent many cosmetics, be confused with the hybrid lavandin (Lavandula x shampoos, and industrial products. Lavender oil is intermedia Emeric ex Loisel), which is more widely used as a flavor component in food products, includ- cultivated and far
    [Show full text]